CouncilIQ
Loading...
Loading...
Loading tenders...
Estimated Value
Not disclosed
Deadline
Not specified
Contract Period
Not specified
Procurement Method
open
Extracted from the notice; check the official documents.
NHS Branded Framework Agreement – Lot 1 - Tranche A for the North of England and Midlands & East. Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months. Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.
ACCORD-UK LTDLarge, AMGEN LIMITEDLarge, AVENTIS PHARMA LIMITED t-a SanofiLarge, BAYER PLCLarge, BIOGEN IDEC LIMITEDLarge, CHUGAI PHARMA LIMITEDSME, CST PHARMA LIMITEDSME, ELI LILLY & COMPANY LTDLarge, GEDEON RICHTER (UK) LIMITEDSME, GLAXOSMITHKLINE UK LIMITEDLarge and 14 more suppliers
£665.4m (total, shared) · Awarded 6 Jul 2026 · Contract ends 31 Aug 2028 · Award notice ↗
BIOGEN IDEC LIMITEDLarge, SANDOZ LIMITEDLarge
£35.3m (total, shared) · Awarded 6 Jul 2026 · Contract ends 31 Aug 2027 · Award notice ↗
From award notices on Find a Tender and Contracts Finder. SME or Large is the size the supplier declared on the notice (or, where it is silent, on its latest notice). Values are as published.